article Open AccessTop 1% cited
Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin
Archives of Ophthalmology · 1999 · Vol. 117(10) · pp. 1329–1329
Abstract
The visual acuity benefits of verteporfin therapy for AMD patients with predominantly classic CNV subfoveal lesions are safely sustained for 2 years, providing more compelling evidence to use verteporfin therapy for these cases. For AMD patients with subfoveal lesions that are minimally classic, there is insufficient evidence to warrant routine use of verteporfin therapy.
Retinal Diseases and TreatmentsOcular Diseases and Behçet’s SyndromeRetinal Imaging and AnalysisVerteporfinChoroidal neovascularizationMacular degenerationMedicineOphthalmologyVisual acuityFluorescein angiographySurgery
MeSH terms
VerteporfinAgedDouble-Blind MethodFemaleFluorescein AngiographyFovea CentralisHumansMacular DegenerationMalePhotochemotherapyPorphyrinsSafetyVisual AcuityTreatment OutcomePhotosensitizing Agents
Funding
- University of Miami
- Cleveland Clinic
- Cleveland Clinic Foundation
- Massachusetts Eye and Ear
- Johns Hopkins University
- University of Toronto
- Kementerian Pendidikan Nasional
Citations
2,186
FWCI
73.02
field-weighted impact
References
51
Percentile
100%
vs. same field & year
Citations per year
Cited by
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Ophthalmology · 2012 · 1,702 citations
Prevalence of Age-Related Macular Degeneration in the United States
Archives of Ophthalmology · 2004 · 2,736 citations
Immunological and Toxicological Considerations for the Design of Liposomes
Nanomaterials · 2020 · 347 citations
Macrophage Depletion Inhibits Experimental Choroidal Neovascularization
Investigative Ophthalmology & Visual Science · 2003 · 513 citations
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2
American Journal of Ophthalmology · 2001 · 813 citations
Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration
Ophthalmology · 2016 · 690 citations
A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation With Vitamins C and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss
Archives of Ophthalmology · 2001 · 3,223 citations
Clinical Characteristics of Exudative Age-related Macular Degeneration in Japanese Patients
American Journal of Ophthalmology · 2007 · 542 citations
References
Prevalence of Age-related Maculopathy
Ophthalmology · 1992 · 1,834 citations
Age-related Macular Degeneration Histopathologic Studies
Ophthalmology · 1993 · 749 citations
The Prevalence of Age-related Maculopathy in the Rotterdam Study
Ophthalmology · 1995 · 819 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.